What cardiac defect is most commonly associated with DiGeorge (22q11.2 deletion) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cardiac Defects in DiGeorge Syndrome (22q11.2 Deletion Syndrome)

The most common cardiac defects in DiGeorge syndrome are conotruncal defects, specifically tetralogy of Fallot, interrupted aortic arch type B, and truncus arteriosus. 1

Prevalence and Pattern

Congenital heart disease (CHD) occurs in approximately 60-80% of patients with 22q11.2 deletion syndrome. 1, 2 The cardiac manifestations follow a distinctive pattern that should raise clinical suspicion for this genetic condition.

Specific Cardiac Defects

Major Conotruncal Defects (Most Common)

The hallmark cardiac lesions include:

  • Tetralogy of Fallot - the most frequently encountered major defect 1, 2
  • Interrupted aortic arch type B - highly associated with 22q11.2 deletion 1, 2
  • Truncus arteriosus - another classic conotruncal anomaly 1, 2
  • Pulmonary atresia with ventricular septal defect - often with major aortopulmonary collaterals 1

Additional Cardiac Features

Beyond the primary conotruncal defects, several associated anomalies increase diagnostic suspicion:

  • Ventricular septal defects - actually the most common overall cardiac finding, though considered "minor" CHD 1
  • Aortic arch anomalies - including right aortic arch and aberrant subclavian artery 1, 3
  • Crossed pulmonary arteries 1
  • Vascular rings - can cause tracheal/esophageal compression presenting as stridor or feeding difficulties 1

Clinical Significance for Diagnosis

The presence of an aortic arch anomaly concurrent with any conotruncal defect strongly predicts 22q11.2 deletion status (odds ratio 5.07). 4 This combination should prompt immediate genetic testing.

Current screening guidelines recommend testing for 22q11.2 deletion in patients with:

  • Tetralogy of Fallot 2
  • Truncus arteriosus 2
  • Interrupted aortic arch type B 2
  • Conoventricular septal defects 2
  • Isolated aortic arch anomalies 2

Surgical Considerations

Patients with 22q11.2 deletion and cardiac defects face increased perioperative complications despite similar mortality rates compared to non-syndromic patients. 1, 5 These complications include:

  • Prolonged mechanical ventilation 1
  • Extended hospital stays 1
  • Higher risk with pulmonary atresia/VSD and interrupted aortic arch 5

The complex anatomy typically requires intracardiac repair in infancy or early childhood, with frequent need for reintervention during childhood and adolescence. 1

Long-Term Cardiac Surveillance

All patients with 22q11.2 deletion require periodic cardiac surveillance regardless of whether CHD was initially present. 1 This includes monitoring for:

  • Dilated aortic root 1
  • Arrhythmias 1
  • Progressive valvular dysfunction in those with prior surgical repair 1

Genetic Mechanism

The cardiac phenotype results from haploinsufficiency of genes in the 22q11.2 region, particularly TBX1, which causes dysfunction of neural crest cells and the anterior heart field during embryonic development. 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

22q11.2 deletion syndrome and congenital heart disease.

American journal of medical genetics. Part C, Seminars in medical genetics, 2020

Research

Cardiac defects and results of cardiac surgery in 22q11.2 deletion syndrome.

Developmental disabilities research reviews, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.